{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T02:18:38Z","timestamp":1768529918592,"version":"3.49.0"},"reference-count":27,"publisher":"International Union Against Tuberculosis and Lung Disease","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJTLD Open"],"accepted":{"date-parts":[[2025,8,4]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Globally, 10.6 million TB cases occurred in 2021. Malaysia reported 25,000 TB cases in 2022, and also has a high prevalence of diabetes mellitus (DM), amplifying TB risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Assess the cost-effectiveness of QuantiFERON (QFT-plus) versus tuberculin skin test (TST) for diagnosing TB infection in patients with DM in Malaysia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Using an R-based model, we compared QFT-plus to TST. The analysis included individuals with HbA1C &gt;10%. Primary outcomes encompassed costs, quality-adjusted life-years (QALYs), and averted TB cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>QFT-plus costs US$111.29 per person versus US$285.66 for TST. It generated 16.51 QALYs per person, compared to 16.50 QALYs for TST. Despite higher initial screening costs, its improved diagnostic accuracy enables earlier treatment, reducing active TB progression risk by 26% compared to TST. Both deterministic and probabilistic sensitivity analyses consistently favoured QFT-plus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Despite its higher initial cost, QFT-plus is both more economical and clinically superior to TST in the context of Malaysia\u2019s high prevalence of DM. This underscores the need for its broader adoption through policy shifts to incorporate QFT-plus into national guidelines. Future research should address implementation and broader socio-economic aspects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5588\/ijtldopen.25.0311","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T11:08:01Z","timestamp":1765796881000},"page":"739-744","source":"Crossref","is-referenced-by-count":0,"title":["A cost-effectiveness evaluation of methods for screening for TB infection in patients with diabetes mellitus"],"prefix":"10.5588","volume":"2","author":[{"given":"M.I.","family":"Mahmood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ganason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.A.","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.H.","family":"Ramli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.H.A.","family":"Halim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3554","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"2026011502221393000_2.12.739.1","unstructured":"World Health Organization . Global tuberculosis report 2022. Geneva: WHO, 2022."},{"key":"2026011502221393000_2.12.739.2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002152"},{"issue":"6","key":"2026011502221393000_2.12.739.3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S2213-2600(24)00028-6","article-title":"Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise","volume":"12","author":"Coussens","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"1","key":"2026011502221393000_2.12.739.4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12931-023-02414-5","article-title":"Diabetes severity is strongly associated with the risk of active tuberculosis in people with type 2 diabetes: a nationwide cohort study with a 6-year follow-up","volume":"24","author":"Kang","year":"2023","journal-title":"Respir Res"},{"key":"2026011502221393000_2.12.739.5","unstructured":"IDF . IDF diabetes atlas 2021. Brussels, Belgium: IDF, 2021. https:\/\/diabetesatlas.org\/atlas\/tenth-edition\/."},{"key":"2026011502221393000_2.12.739.6","unstructured":"MoH Malaysia . National health and morbidity survey 2019 non-communicable diseases, healthcare demand, and health literacy. Kuala Lumpur, Malaysia: Institute for Public Health (IPH), Ministry of Health Malaysia, 2019. https:\/\/iptk.moh.gov.my\/images\/technical_report\/2020\/4_Infographic_Booklet_NHMS_2019_-_English.pdf."},{"issue":"6","key":"2026011502221393000_2.12.739.7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/cid\/ciw836","article-title":"Diabetes mellitus and latent tuberculosis infection: a systemic review and metaanalysis","volume":"64","author":"Lee","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2026011502221393000_2.12.739.8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5588\/ijtld.15.0457","article-title":"Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus HHS Public Access","volume":"20","author":"Hensel","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026011502221393000_2.12.739.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-029948"},{"key":"2026011502221393000_2.12.739.10","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1687"},{"issue":"11","key":"2026011502221393000_2.12.739.11","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"Farhat","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026011502221393000_2.12.739.12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-3-200808050-00241"},{"key":"2026011502221393000_2.12.739.13","unstructured":"World Health Organization . Use of alternative interferon-gamma release assays for the diagnosis of TB infection: WHO policy statement. Geneva: WHO, 2022."},{"key":"2026011502221393000_2.12.739.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2019.08.018"},{"key":"2026011502221393000_2.12.739.15","doi-asserted-by":"crossref","unstructured":"World Health Organization . WHO consolidated guidelines on tuberculosis: module 1: prevention: infection prevention and control. Geneva: WHO, 2022.","DOI":"10.30978\/TB2021-2-86"},{"issue":"11","key":"2026011502221393000_2.12.739.16","doi-asserted-by":"crossref","first-page":"e012297","DOI":"10.1136\/bmjgh-2023-012297","article-title":"A costing framework to compare tuberculosis infection tests","volume":"8","author":"Brumwell","year":"2023","journal-title":"BMJ Glob Heal"},{"key":"2026011502221393000_2.12.739.17","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/s41598-023-29648-z","article-title":"A cost-effectiveness evaluation of latent tuberculosis infection screening of a migrant population in Malaysia","volume":"13","author":"Barker","year":"2023","journal-title":"Sci Rep"},{"key":"2026011502221393000_2.12.739.18","unstructured":"LeAd NCD Malaysia . National Diabetes Registry Report 2020 - LeAd NCD Malaysia. Putrajaya, Malaysia: LeAd NCD Malaysia, 2020. https:\/\/leadncdmalaysia.com\/national-diabetes-registry-report-2020\/."},{"issue":"1","key":"2026011502221393000_2.12.739.19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/ijerph18010305","article-title":"Prevalence and risk factors of latent tuberculosis infection (LTBI) in patients with type 2 diabetes mellitus (T2DM)","volume":"18","author":"Ping","year":"2021","journal-title":"Int J Environ Res Public Heal"},{"key":"2026011502221393000_2.12.739.20","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-023-02175-8"},{"key":"2026011502221393000_2.12.739.21","doi-asserted-by":"crossref","first-page":"625078","DOI":"10.3389\/fphar.2021.625078","article-title":"Adherence and associated factors of treatment regimen in drug-susceptible tuberculosis patients","volume":"12","author":"Bea","year":"2021","journal-title":"Front Pharmacol"},{"issue":"6","key":"2026011502221393000_2.12.739.22","doi-asserted-by":"crossref","first-page":"e1252","DOI":"10.1093\/cid\/ciab209","article-title":"Completion rate and safety of programmatic screening and treatment for latent tuberculosis infection in elderly patients with poorly controlled diabetic mellitus: a prospective multicenter study","volume":"73","author":"Huang","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026011502221393000_2.12.739.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1076-0"},{"key":"2026011502221393000_2.12.739.24","unstructured":"World Health Organization . Bacillus Calmette\u2013Gu\u00e9rin (BCG) vaccination coverage. Geneva: WHO, 2022. https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/bacillus-calmette-gu\u00e9rin-(bcg)-vaccination-coverage?CODE=Global&YEAR=."},{"key":"2026011502221393000_2.12.739.25","doi-asserted-by":"publisher","DOI":"10.1023\/B:QURE.0000021320.89524.64"},{"key":"2026011502221393000_2.12.739.26","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-7-14"},{"key":"2026011502221393000_2.12.739.27","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00499-2023"}],"container-title":["IJTLD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.5588\/ijtldopen.25.0311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:24:53Z","timestamp":1768472693000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.theunion.org\/lookup\/doi\/10.5588\/ijtldopen.25.0311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,1]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.5588\/ijtldopen.25.0311"],"URL":"https:\/\/doi.org\/10.5588\/ijtldopen.25.0311","relation":{},"ISSN":["3005-7590"],"issn-type":[{"value":"3005-7590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}